Zeelab Pharmacy: Comprehensive 2026 Company Profile & Overview
Discover Zeelab Pharmacy's 2026 profile & overview. Learn about its financial highlights, funding rounds, and cap table details in the Health Tech industry.
LazyFounders
30 SEC SUMMARY
- Get an in-depth 2026 profile of Zeelab Pharmacy, a leading player in the Health Tech industry.
- Explore financial highlights, funding rounds, and cap table details.
- Understand the company's expansion from generic medicines to a wide range of healthcare products.
TABLE OF CONTENTS
Introduction
Zeelab Pharmacy, founded in 2018, has emerged as a significant player in the Health Tech industry. Initially focusing on generic medicines, the company has expanded its offerings to include a wide range of healthcare products. With a robust financial performance, Zeelab Pharmacy continues to grow and innovate in the competitive landscape of Health Tech.
Company Profile
Zeelab Pharmacy operates under the umbrella of ZEE LABORATORIES LIMITED. The company has demonstrated impressive growth, achieving a revenue of ₹461.3 Cr+ in FY24. Zeelab Pharmacy's journey from a niche player to a market leader highlights its commitment to quality and innovation in the healthcare sector.
Financial Highlights
In FY24, Zeelab Pharmacy reported a substantial revenue of ₹461.3 Cr+. This significant financial milestone underscores the company's robust performance and market presence. The company's financial health is further bolstered by strategic investments and expansions in its product portfolio.
Funding Overview
Zeelab Pharmacy has successfully navigated multiple funding rounds, attracting investments from prominent venture capital firms. These funding rounds have provided the necessary capital to fuel the company's growth and innovation initiatives. Detailed information on the funding rounds can be found in the cap table summary below.
Cap Table Summary
The cap table summary of Zeelab Pharmacy provides a detailed overview of the company's shareholding pattern. This includes the distribution of equity among founders, investors, and other stakeholders. The cap table is a crucial document that reflects the company's ownership structure and investment history.
FAQs
What is Zeelab Pharmacy's primary focus?
Zeelab Pharmacy primarily focuses on the Health Tech industry, offering a wide range of healthcare products beyond just generic medicines.
What was Zeelab Pharmacy's revenue in FY24?
Zeelab Pharmacy reported a revenue of ₹461.3 Cr+ in FY24.
Who are the major investors in Zeelab Pharmacy?
Zeelab Pharmacy has attracted investments from prominent venture capital firms, although specific names are detailed in the cap table summary.
Conclusion
Zeelab Pharmacy's journey from its inception in 2018 to its current status as a leading entity in the Health Tech industry is a testament to its strategic vision and operational excellence. With continued growth and innovation, Zeelab Pharmacy is well-positioned to maintain its market leadership.
Call-to-Action
For more detailed insights into Zeelab Pharmacy's operations, funding, and financials, visit blogy.in. Unlock the full operating picture of this dynamic company today!
Sources
This story is an original summary and analysis written by LazyFounders from the reporting listed above. Facts are attributed to their original publishers; sections marked as analysis are LazyFounders's opinion. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links.
